NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 56 filers reported holding NUVALENT INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,710,119 | -7.3% | 2,451,819 | -15.0% | 13.56% | -20.9% |
| Q2 2023 | $121,639,028 | +61.6% | 2,884,492 | 0.0% | 17.15% | +32.5% |
| Q1 2023 | $75,256,396 | -9.4% | 2,884,492 | +3.4% | 12.94% | -1.8% |
| Q4 2022 | $83,055,854 | +105.4% | 2,788,981 | +34.1% | 13.18% | +85.4% |
| Q3 2022 | $40,433,000 | +73.8% | 2,079,863 | +21.2% | 7.11% | +33.5% |
| Q2 2022 | $23,262,000 | +25.1% | 1,715,518 | +28.2% | 5.32% | +21.1% |
| Q1 2022 | $18,590,000 | +6.8% | 1,338,393 | +46.3% | 4.40% | -23.4% |
| Q4 2021 | $17,414,000 | -15.6% | 914,614 | 0.0% | 5.74% | -23.5% |
| Q3 2021 | $20,625,000 | – | 914,614 | – | 7.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,884,492 | $75,256,396 | 12.94% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $93,331 | 11.66% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $521,565,816 | 11.63% |
| COMMODORE CAPITAL LP | 1,075,000 | $28,046,750 | 4.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 281,533 | $7,345,196 | 3.03% |
| Perceptive Advisors | 2,300,048 | $60,008,252 | 1.77% |
| Boxer Capital, LLC | 1,210,192 | $31,574 | 1.55% |
| Avoro Capital Advisors LLC | 1,888,888 | $49,281,088 | 0.73% |
| Soleus Capital Management, L.P. | 236,900 | $6,180,721 | 0.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,402,525 | $36,591,877 | 0.51% |